195 related articles for article (PubMed ID: 38266047)
1. Astrocytic TIMP-1 regulates production of Anastellin, an inhibitor of oligodendrocyte differentiation and FTY720 responses.
Sutter PA; Willis CM; Menoret A; Nicaise AM; Sacino A; Sikkema AH; Jellison ER; Win KK; Han DK; Church W; Baron W; Vella AT; Crocker SJ
Proc Natl Acad Sci U S A; 2024 Jan; 121(5):e2306816121. PubMed ID: 38266047
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic TIMP-1 regulates production of Anastellin, a novel inhibitor of oligodendrocyte differentiation and FTY720 responses.
Sutter PA; Willis CM; Menoret A; Nicaise AM; Sacino A; Sikkema AH; Jellison E; Win KK; Han DK; Church W; Baron W; Vella AT; Crocker SJ
bioRxiv; 2023 Feb; ():. PubMed ID: 36824834
[TBL] [Abstract][Full Text] [Related]
3. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
[TBL] [Abstract][Full Text] [Related]
4. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
[TBL] [Abstract][Full Text] [Related]
5. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
[TBL] [Abstract][Full Text] [Related]
6. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
Tsai HC; Huang Y; Garris CS; Moreno MA; Griffin CW; Han MH
JCI Insight; 2016 Jun; 1(9):e86462. PubMed ID: 27699272
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.
Rothhammer V; Kenison JE; Tjon E; Takenaka MC; de Lima KA; Borucki DM; Chao CC; Wilz A; Blain M; Healy L; Antel J; Quintana FJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2012-2017. PubMed ID: 28167760
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
9. Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination.
Moore CS; Milner R; Nishiyama A; Frausto RF; Serwanski DR; Pagarigan RR; Whitton JL; Miller RH; Crocker SJ
J Neurosci; 2011 Apr; 31(16):6247-54. PubMed ID: 21508247
[TBL] [Abstract][Full Text] [Related]
10. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Brinkmann V
Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.
Houben E; Janssens K; Hermans D; Vandooren J; Van den Haute C; Schepers M; Vanmierlo T; Lambrichts I; van Horssen J; Baekelandt V; Opdenakker G; Baron W; Broux B; Slaets H; Hellings N
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):5028-5038. PubMed ID: 32071226
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.
Miron VE; Ludwin SK; Darlington PJ; Jarjour AA; Soliven B; Kennedy TE; Antel JP
Am J Pathol; 2010 Jun; 176(6):2682-94. PubMed ID: 20413685
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
[TBL] [Abstract][Full Text] [Related]
14. Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process.
Yazdi A; Ghasemi-Kasman M; Javan M
J Neurosci Res; 2020 Mar; 98(3):524-536. PubMed ID: 31385341
[TBL] [Abstract][Full Text] [Related]
15. TIMP-1 couples RhoK activation to IL-1β-induced astrocyte responses.
Johnson KM; Crocker SJ
Neurosci Lett; 2015 Nov; 609():165-70. PubMed ID: 26484505
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
Kocovski P; Tabassum-Sheikh N; Marinis S; Dang PT; Hale MW; Orian JM
Front Immunol; 2021; 12():639650. PubMed ID: 34177891
[TBL] [Abstract][Full Text] [Related]
17. A Functionally Defined
Groves A; Kihara Y; Jonnalagadda D; Rivera R; Kennedy G; Mayford M; Chun J
eNeuro; 2018; 5(5):. PubMed ID: 30255127
[TBL] [Abstract][Full Text] [Related]
18. Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.
Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
Mol Ther; 2017 Feb; 25(2):401-415. PubMed ID: 28153091
[TBL] [Abstract][Full Text] [Related]
19. Relapse of experimental autoimmune encephalomyelitis after discontinuation of FTY720 (Fingolimod) treatment, but not after combination of FTY720 and pathogenic autoantigen.
Yoshida Y; Tsuji T; Fujita T; Kohno T
Biol Pharm Bull; 2011; 34(6):933-6. PubMed ID: 21628899
[TBL] [Abstract][Full Text] [Related]
20. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP
Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
